VAUGHAN, Ontario - Bausch + Lomb Corporation (NYSE/TSX: BLCO), a prominent eye health company with a market capitalization of $6.25 billion, has announced the conclusion of its search for a ...

(Reuters) -Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday. In December, the company said it was exploring a potential sale and other options that ...

Bengaluru: Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday, sending its U.S.-listed shares down 7per cent to $16.50 in premarket trading. The company ...

(Reuters) -Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday, sending its U.S.-listed shares down 7% to $16.50 in premarket trading. The company had said in ...

The announcement comes after a request was made by the Canadian Investment Regulatory Organization (CIRO) to explore the ...

(Reuters) -Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday. In December, the company said it was exploring a potential sale and other options that would ...

Bausch Health Companies Inc.’s years-long process of trying to separate its Bausch + Lomb Corp. eye-care business hit a roadblock Thursday when a potential sale to private equity fell through ...

Bausch + Lomb announced today that, after engagement with potential buyers, it has no immediate plan to sell. At the end of 2024, the company issued a statement outlining its plans for a potential ...